Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CI NYSE:CNC NYSE:HUM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCICigna Group$286.64+1.0%$286.59$239.51▼$315.47$75.84B0.291.68 million shs339,173 shsCNCCentene$66.86+1.5%$62.95$25.08▼$69.36$33.03B1.076.08 million shs1.03 million shsHUMHumana$406.07+2.0%$356.50$163.11▼$428.88$48.69B0.711.82 million shs146,964 shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCICigna Group+0.81%-6.76%+1.57%+2.89%-3.81%CNCCentene-0.62%-3.66%+7.90%+68.39%+135.71%HUMHumana-0.69%-1.99%+10.23%+82.59%+80.72%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCICigna Group$286.64+1.0%$286.59$239.51▼$315.47$75.84B0.291.68 million shs339,173 shsCNCCentene$66.86+1.5%$62.95$25.08▼$69.36$33.03B1.076.08 million shs1.03 million shsHUMHumana$406.07+2.0%$356.50$163.11▼$428.88$48.69B0.711.82 million shs146,964 shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCICigna Group+0.81%-6.76%+1.57%+2.89%-3.81%CNCCentene-0.62%-3.66%+7.90%+68.39%+135.71%HUMHumana-0.69%-1.99%+10.23%+82.59%+80.72%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCICigna Group 2.77Moderate Buy$338.8019.29% UpsideCNCCentene 2.25Hold$64.61-1.93% DownsideHUMHumana 2.39Hold$327.17-17.74% DownsideCurrent Analyst Ratings BreakdownLatest CI, HUM, and CNC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/20/2026HUMHumana Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral$410.007/17/2026CNCCentene Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)7/14/2026HUMHumana TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$211.00 ➝ $350.007/14/2026CNCCentene TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold$47.00 ➝ $65.007/14/2026CNCCentene Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$71.00 ➝ $78.007/14/2026HUMHumana Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$320.00 ➝ $415.007/13/2026CNCCentene Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetEqual Weight$56.00 ➝ $69.007/13/2026HUMHumana Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeEqual Weight ➝ Overweight$227.00 ➝ $502.007/13/2026HUMHumana Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy7/9/2026HUMHumana Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetSector Perform$246.00 ➝ $415.007/9/2026CICigna Group Sanford C. BernsteinSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$371.00 ➝ $381.00(Data available from 7/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCICigna Group$276.88B0.27$41.34 per share6.87$158.90 per share1.79CNCCentene$194.78B0.17$4.65 per share14.18$40.76 per share1.62HUMHumana$129.66B0.37$23.93 per share16.62$147.47 per share2.70Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCICigna Group$5.96B$23.5912.048.501.082.26%19.75%5.30%7/30/2026 (Estimated)CNCCentene-$6.67B-$13.14N/A14.870.52-3.25%5.57%1.54%7/28/2026 (Estimated)HUMHumana$1.19B$9.3542.5425.632.160.82%10.45%3.75%7/29/2026 (Estimated)Latest CI, HUM, and CNC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/30/2026Q2 2026CICigna Group$7.58N/AN/AN/A$70.14 billionN/A7/29/2026Q2 2026HUMHumana$7.25N/AN/AN/A$40.57 billionN/A7/28/2026Q2 2026CNCCentene$1.08N/AN/AN/A$47.64 billionN/A4/30/2026Q1 2026CICigna Group$7.60$7.79+$0.19$6.26$66.29 billion$68.52 billion4/29/2026Q1 2026HUMHumana$9.97$10.31+$0.34$9.83$39.37 billion$39.65 billion4/28/2026Q1 2026CNCCentene$2.23$3.37+$1.14$3.11$47.53 billion$49.94 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCICigna Group$6.242.18%+172.77%26.45%5 YearsCNCCenteneN/AN/AN/AN/AN/AHUMHumana$3.540.87%+7.20%37.86%N/ALatest CI, HUM, and CNC DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/22/2026CICigna Groupquarterly$1.562.22%6/4/20266/4/20266/18/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCICigna Group0.690.730.73CNCCentene0.761.121.12HUMHumana0.661.771.77Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCICigna Group86.99%CNCCentene93.63%HUMHumana92.38%Insider OwnershipCompanyInsider OwnershipCICigna Group0.60%CNCCentene0.37%HUMHumana0.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCICigna Group67,700264.53 million262.95 millionOptionableCNCCentene61,100493.80 million491.97 millionOptionableHUMHumana67,060120.06 million119.82 millionOptionableCI, HUM, and CNC HeadlinesRecent News About These CompaniesHumana Inc. $HUM Shares Sold by Bank of New York Mellon CorpJuly 21 at 3:28 AM | marketbeat.comHeartland Advisors Inc. Sells 2,535 Shares of Humana Inc. $HUMJuly 20 at 5:20 AM | marketbeat.comFifth Third Bancorp Has $3.98 Million Stock Position in Humana Inc. $HUMJuly 19 at 3:35 AM | marketbeat.comWatershed Asset Management L.L.C. Takes $474,000 Position in Humana Inc. $HUMJuly 18 at 6:39 AM | marketbeat.comZacks Research Weighs in on Humana's Q4 Earnings (NYSE:HUM)July 18 at 1:42 AM | americanbankingnews.comHumana AB: Humana reports second quarter and half-year 2026 resultsJuly 17, 2026 | finanznachrichten.deIs Humana (HUM) Stock Outpacing Its Medical Peers This Year?July 17, 2026 | zacks.comHumana boosts profitability and cash flow despite muted growth in Q2 2026July 17, 2026 | tipranks.comCan Humana (HUM) Run Higher on Rising Earnings Estimates?July 16, 2026 | zacks.comHumana (NYSE:HUM) Hits New 52-Week High - Here's What HappenedJuly 16, 2026 | marketbeat.comMedicare's $50 Weight-Loss Drug Window Opens In July: What Smart Enrollees Do Before 2027July 16, 2026 | benzinga.comBrokers Set Expectations for Humana's Q4 Earnings (NYSE:HUM)July 16, 2026 | marketbeat.comHumana: Q2 Earnings Must Catch Up With The StockJuly 15, 2026 | seekingalpha.comHumana (HUM) Rallies On Conflicting Valuation Views, Is It Fully Priced?July 15, 2026 | finance.yahoo.comZacks Research Issues Positive Outlook for Humana EarningsJuly 15, 2026 | marketbeat.comHumana (NYSE:HUM) Upgraded by Zacks Research to "Strong-Buy" RatingJuly 15, 2026 | marketbeat.comHumana (NYSE:HUM) Price Target Raised to $415.00 at Truist FinancialJuly 15, 2026 | americanbankingnews.comAgreement between Wexner Medical Center, Humana set to end in OctoberJuly 14, 2026 | msn.comHumana (NYSE:HUM) Price Target Raised to $415.00July 14, 2026 | marketbeat.comHumana insurance network terminating agreement with Ohio StateJuly 13, 2026 | msn.comHumana Eyes 3% Medicare Advantage Margin: Can It Deliver?July 13, 2026 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSK Hynix’s Nasdaq Listing Could Reset the AI Memory TradeBy Thomas Hughes | July 7, 2026Micron’s Sudden Plunge May Be an AI Buying ChanceBy Jeffrey Neal Johnson | June 23, 2026Oracle’s Sell-Off Looks More Like a Mispricing Than a WarningBy Thomas Hughes | June 23, 2026The SpaceX Sell-Off May Be More Than a Market OverreactionBy Jeffrey Neal Johnson | June 24, 2026AirJoule Unveils Prime System, Clearing Path to CommercializationBy Thomas Hughes | July 1, 2026CI, HUM, and CNC Company DescriptionsCigna Group NYSE:CI$286.64 +2.70 (+0.95%) As of 11:44 AM Eastern This is a fair market value price provided by Massive. Learn more.The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.Centene NYSE:CNC$66.86 +1.02 (+1.55%) As of 11:45 AM Eastern This is a fair market value price provided by Massive. Learn more.Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.Humana NYSE:HUM$406.07 +7.87 (+1.98%) As of 11:45 AM Eastern This is a fair market value price provided by Massive. Learn more.Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Buy, Hold, or Wait: 3 Small-Cap Stocks Telling Different Stories The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino's Stock Serving Up a Buying Opportunity? IBM Just Had Its Worst Day Ever—What Earnings Must Prove AI Data Centers Need Power, and These 2 Industrials Are Cashing In 5 Stocks Quietly Trading Near All-Time Highs While Everyone Watches the AI Drama Meta Platforms Turns AI Power Scarcity Into a $10 Billion Cloud Bet Oracle Is One Step From Junk—Can It Afford the AI Boom? Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
